Contravisory Investment Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,006
| Closed | -$170K | – | 415 |
|
|
2023
Q3 | $170K | Buy |
11,006
+705
| +7% | +$10.9K | 0.05% | 204 |
|
|
2023
Q2 | $162K | Buy |
10,301
+3,999
| +63% | +$62.8K | 0.04% | 208 |
|
|
2023
Q1 | $104K | Buy |
6,302
+591
| +10% | +$9.74K | 0.03% | 216 |
|
|
2022
Q4 | $89.1K | Sell |
5,711
-11
| -0.2% | -$172 | 0.02% | 224 |
|
|
2022
Q3 | $74K | Hold |
5,722
| – | – | 0.02% | 224 |
|
|
2022
Q2 | $80K | Buy |
+5,722
| New | +$80K | 0.03% | 226 |
|
|
2020
Q4 | – | Sell |
-1,458
| Closed | -$26K | – | 275 |
|
|
2020
Q3 | $26K | Hold |
1,458
| – | – | 0.01% | 212 |
|
|
2020
Q2 | $28K | Sell |
1,458
-86
| -6% | -$1.65K | 0.01% | 210 |
|
|
2020
Q1 | $23K | Buy |
1,544
+77
| +5% | +$1.15K | 0.01% | 231 |
|
|
2019
Q4 | $29K | Sell |
1,467
-17
| -1% | -$336 | 0.01% | 230 |
|
|
2019
Q3 | $26K | Buy |
1,484
+86
| +6% | +$1.51K | 0.01% | 236 |
|
|
2019
Q2 | $25K | Hold |
1,398
| – | – | 0.01% | 236 |
|
|
2019
Q1 | $28K | Buy |
+1,398
| New | +$28K | 0.01% | 241 |
|